Top 50 Life Science VC (Venture Capital) Funds in China in October 2024
A list of 50 VC (Venture Capital) funds that invest in Life science startups based in China. We rank investors based on the number of investments they made in Life science companies from China. We update this investor list every month.Top 50 Life Science VC (Venture Capital) Funds in China in October 2024
We help founders build enduring companies.
Show more
Investment focus
- Biotechnology, Health Care, Artificial Intelligence
- Series A, Series B, Series C
- China, United States, Australia
Portfolio highlights
- Dongchedi — The company's platform users interests and hobbies and automatically recommends content, information, and vehicle quotations related to new cars and used cars, providing users with knowledge and car industry information.
- Sanshou Technology — Sanshou Technology focuses on researching and developing smart motorcycles.
- RD Technologies — RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
- LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
- Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- dinii — Dinii is a mobile order platform for take-out shops.
- Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Angel
- China, United States, Hong Kong
Portfolio highlights
- Baijun Biotech — Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.
- Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
- Ai Sensing Technology — Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Seed, Series A
- China, United States, United Kingdom
Portfolio highlights
- Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
- Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Series A, Series B, Series C
- United States, China, Israel
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Series A, Angel, Series C
- China
Portfolio highlights
- Shanghai Bioprofile — Shanghai Bioprofile is a metabonomics technology service provider.
- Lingyun Microelectronics — Lingyun Microelectronics is a manufacturer of high-speed digital-analog hybrid interfaces and control processors.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Taiwan
Portfolio highlights
- Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
- Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
- Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more
Investment focus
- Manufacturing, Semiconductor, Hardware
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Glazero Technology — Established in Dec 2020, Glazero is a brand that provides smart home solutions to global markets. It focuses on AIot smart home products, covering smart security, smart lighting and smart cleaning products. Glazero starts from the North American home appliance market, and sells through cross-border e-commerce platforms.
- Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
- Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.
ULTIMA is an investment management firm.
Show more
Investment focus
- Hardware, Software, Agriculture
- Angel, Series A
- China
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more
Investment focus
- Artificial Intelligence, Software, Information Technology
- Seed, Angel, Pre-Seed
- China, United States, Singapore
Portfolio highlights
- Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
- Hanhai Energy — Hanhai Energy is dedicated to explore the science and technology to accelerate the commercialization of fusion energy.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
- Ensurge Medical — Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.
- Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
BOHE Angel Fund is an investment Fund.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Angel, Seed, Series A
- China
Portfolio highlights
- Levostar — Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products.
- Singlomics — Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.
- Shuimu BioSciences — Shuimu BioSciences Ltd. was founded in 2017 in Beijing, China, to bring the power of Cryo-EM to new therapeutics developers through a differentiated service offering, making the method accessible and affordable for Discovery teams at all stages of method adoption. We are the first commercial full service Cryo-EM platform in Asia, led by top expertsfrom Tsinghua University and experienced industry executives. All of our work is performed with the quality controls and service levels expected of a top tier contract research organization.
Puhua Capital is an equity investment firm that focuses on early and middle project.
Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Angel
- China, United Kingdom, United States
Portfolio highlights
- Glbizzia — Glbizzia is a company specializing in genetic testing, data utilization, and biological breeding platforms, focusing on high-throughput omics big data analysis, intelligent omics experiments, and scientific research consulting.
- Garen Semiconductor — Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide).
- ICleague Technology — ICleague Technology to satisfy situations requiring high processing power, high bandwidth, and low power consumption.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Kenya
Portfolio highlights
- Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
- Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
- Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
Loyal Valley Capital is a thematic, research-driven private equity firm.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series C, Series B, Series A
- China, United States, Hong Kong
Portfolio highlights
- Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
- DP Technology — DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D.DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trainedlarge science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.
- DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Series B, Seed
- China, United States, South Korea
Portfolio highlights
- RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
- Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
- weshare — Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide throughcontinuous exploration and technologies.
Green Pine Capital Partners is a venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Manufacturing, Software
- Series A, Angel, Series B
- China, United States, Canada
Portfolio highlights
- Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
- Neurogin — Neurogin is a bioelectronics company that provides reliable monitoring and auxiliary diagnostic tools for clinical and health institutions and focuses on advanced engineering methods for brain science research and clinical diagnosis.
- Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
- Targeting One — Targeting One is an in-vitro diagnostic product developer.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
BMC engaged in asset management, investment management and consulting.
Show more
Investment focus
- CAD, Medical, Computer
- Seed, Series B
- China
Portfolio highlights
- Shengshi Technology — Shengshi Technology is a CFD experimental simulation AI-based platform that does medical engineering research on cardiovascular diseases.
- Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.
- Timesintelli — Timesintelli focuses on the development of various end-side artificial intelligence processing chips. The company provides support for a wide range of end-side devices, such as voice, vision, image, display, and other multi-modal intelligent human-computer interactions. Starting from the needs of the landing scene, through the domain-specificarchitecture and customized chip design in the AIoT era where everything is connected.
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Lucion is an influential professional venture capital institute.
Show more
Investment focus
- Biotechnology, Medical, Manufacturing
- Series A, Series B, Seed
- China
Portfolio highlights
- Keylights — Keylights focuses on the research and development, production, and sales of in vitro diagnostic instruments, it supplies domestic and international consumers with ultra-stable, high-performance, and cost-effective goods and CDMO services.
- Runfu Power — Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
- ThunderBio Innovation — ThunderBio Innovation engages in business includes tumor screening based on the digital biopsy technology of microfluidic chip, etc.
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- Sensview — Sensview specializes in the development and production of solid-state imaging chips and detector modules.
- Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Series A, Seed, Series B
- China, Israel, Singapore
Portfolio highlights
- Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
- Mojia Bioscience — Mojia Bioscience is a biotechnology company.
- Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series B, Series A, Series C
- United States, China, India
Portfolio highlights
- Odaseva — Odaseva is the leading enterprise data platform for Salesforce. Industry leaders rely on Odaseva to keep data protected, compliant, and agile.
- Feon — Feon is pioneering new-molecule-based liquid electrolytes for advanced batteries. We are a "pharmaceutical company" in the battery space, creating "new drug molecules" to treat the "diseases" of next generation batteries.
- Hero Software — Hero Software offers cloud software solutions.
Orient Securities Capital Investment is an private equity fund business platform.
Show more
Investment focus
- Health Care, Manufacturing, Software
- Series A, Series D, Series C
- China
Portfolio highlights
- News Dart — News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.
- HiStarlink — HiStarlink is a commercial company that makes communication technology like space-borne laser communication terminals and core devices. The main product matrix covers aerospace Advanced core optoelectronic devices, ultra-high-speed communication algorithms, laser communication terminals, and satellite-to-ground laser ground receiving systems.
- Shiyu Precision — Shiyu Precision is a high-tech enterprise specializing in the research, development and manufacture of semiconductor automation equipment.
Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.
Show more
Investment focus
- Information Technology, Hotel, Property Management
- Series A, Seed, Series B
- China, Singapore, United States
Portfolio highlights
- Blackpanda — Asia's premier digital forensics and cyber incident response firm.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Gusto Collective — First brandtech group using the latest technology to help brands create content and experiences across the physical and virtual worlds.
Our team invests in early-stage digital health and consumer startups at CentreGold Capital.
Show more
Investment focus
- Medical Device, Artificial Intelligence, Internet
- Seed, Series A, Angel
- United States, China, Canada
Portfolio highlights
- Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
- Virgo Surgical Video Solutions — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
- WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.
Show more
Investment focus
- Artificial Intelligence, Software, Biotechnology
- Seed, Series A, Series B
- China, Hong Kong, United States
Portfolio highlights
- TabbyML — LLM x DevTools + OpenSource
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
- Software, Manufacturing, Information Technology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
- Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.
- Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
- Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
- Phrontline Biopharma — Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more
Investment focus
- Health Care, Manufacturing, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
- Tetrahedron New Energy — Tetrahedron New Energy is an energy technology company that specializes in the development of lithium-ion battery core material solutions.
Cambridge Capital is a private equity fund focused on investing in the health care industry. It is principally engaged in the development of advanced and M & A investments, covering all major health areas such as medicine, medical equipment and medical services. Over the past few years, Cambridge Capital has successfully completed investmentprojects covering a number of medical and health segments such as biopharmaceuticals, drug distribution, molecular diagnostics and medical devices.Cambridge Capital is designed to accelerate the development and marketization of modern medical and medical technology through the use of capital to improve the health of the whole people and benefit mankind.
Show more
Investment focus
- Medical, Health Care, Life Science
- Angel, Series B
- China, United States
Portfolio highlights
- Ascletis — Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China'scapital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases.
- Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
Park Pugao Industrial Fund is an investment fund.
Show more
Investment focus
- Genetics, Life Science, Biotechnology
- Series A
- China
Portfolio highlights
- Super Years — Super Years is a gene technology company that focuses on the research, development, and manufacturing of high-end life science instruments.
Tsing-Yuan Capital is a Chinese venture capital firm specialized in early, middle, and mature stage investments.
Show more
Investment focus
- Manufacturing, Health Care, E-Commerce
- Series A, Angel, Series B
- China, United States
Portfolio highlights
- Soundec — Soundec is an enterprise that focuses on acoustic research and commercialization. The company's products include modules containing software algorithms and audio processing chips, which are mainly used in wired digital headphones and Bluetooth wireless headphones.
- cheaptrustedpharmacy — 4B Technologies is a biotech company that develops novel medicines for neurodegenerative diseases and neurological injuries. Its drug development focuses on reliving pain symptoms from nervous system diseases such as stroke and glaucoma, enabling healthcare professionals to prescribe more effective treatments to their patients.The company wasfounded in 2017 and is based in Suzhou, China.
- Yishi Technology — Yishi Technology is a 3D vision laser sensor R&D manufacturer dedicated to the research and development of intelligent industrial cameras
Zhejiang Zhong Ying Holding Group ia an investment firm.
Show more
Investment focus
- Manufacturing, Solar, Information Technology
- Series A, Angel, Series C
- China
Portfolio highlights
- Derlead — Derlead is a biotechnology company that develops vitro diagnostic reagent products.
- Zhigu Seiko — Zhigu Seiko is a manufacturer of ultra-precision processing technologies and equipment.
- Renshuo Solar — Renshuo Solar is a manufacturer of perovskite tandem solar panels.
Haoping Investment is an investment firm.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- China
Portfolio highlights
- N1 Life — N1 Life is an innovative biomedical company that focused on drug discovery and development of PDC drugs in the anti-tumor pipeline.
Qiji Zhiguang Fund is an investment fund Of BGI.
Show more
Investment focus
- Life Science, Biotechnology
- Angel
- China
Portfolio highlights
- Neurophth Therapeutics — Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
Jinhua Zhencheng Investment Management is engaged in investment management.
Show more
Investment focus
- Agriculture, Life Science, Biotechnology
- Series A
- China
Portfolio highlights
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Jinsheng Group is an investment company.
Show more
Investment focus
- Life Science, Biotechnology
- Series A
- China
Portfolio highlights
- Derlead — Derlead is a biotechnology company that develops vitro diagnostic reagent products.
We focus on control buyouts and recapitalizations of small private companies.
Show more
Investment focus
- Life Science, Therapeutics, Biotechnology
- Seed
- China
Portfolio highlights
- Anticancer Biosciences — Anticancer Bioscience (ACB) is an international private company, commercialising discoveries emerging from China’s world-leading cancer research at the J. Michael Bishop Institute of Cancer Research.
Vulab Tech is an information security firm that provides security a vulnerability management and analysis solution through an AI engine.
Show more
Investment focus
Portfolio highlights
- Smart Cyano — Smart Cyano is a biotech company that integrates research and development, production, and sales of bioactive raw materials. It was established on August 27, 2018 and is headquartered in Qingdao, Fujian, China.
Anhui State-owned Capital is a company that focuses on asset management and disposal, equity management, and capital investment and finance. They also engage in retail sales, real estate construction, and interest income.
Show more
Investment focus
- Genetics, Life Science, Biotechnology
- Series A
- China
Portfolio highlights
- Super Years — Super Years is a gene technology company that focuses on the research, development, and manufacturing of high-end life science instruments.
Shengshan Capital is an investment firm.
Show more
Investment focus
- Biotechnology, AgTech, Genetics
- Series A
- China
Portfolio highlights
- Tekeluo Biotech — Tekeluo Biotech is a Healthcare company.
- Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Shangshi Fund is an investment firm.
Show more
Investment focus
- Information Technology, Hardware, Software
- Series A, Angel, Series B
- China
Portfolio highlights
- Spatomics — Spatomics is focusing on creating a cutting-edge multi-omics tool platform for single cells.
- Aijie Boya — Aijie Boya is a medical instrument and magnetic solid-phase material company.
- Smart Cyano — Smart Cyano is a biotech company that integrates research and development, production, and sales of bioactive raw materials. It was established on August 27, 2018 and is headquartered in Qingdao, Fujian, China.
Zhejiang Laiyi is an investment company.
Show more
Investment focus
- Life Science, Biotechnology
- Series A
- China
Portfolio highlights
- Derlead — Derlead is a biotechnology company that develops vitro diagnostic reagent products.
Yingmeng Capital is an investment firm.
Show more
Investment focus
- Life Science, Biotechnology
- Angel
- China
Portfolio highlights
- Zevi Bio — Zevi Bio is a tumor in situ target capture technology platform.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Retail
Social Media
Medical
Email
Art
Financial Services
Wellness
Music
Infrastructure
Mobile
Franchise
Platforms
Social Network
Local
Internet
Mobile Advertising
Digital Media
Construction
Biotechnology
Manufacturing
eSports
Hospitality
Sports
Fitness
Enterprise Software
Legal
Travel
Android
Recruiting
Cannabis
Wine And Spirits
CleanTech
Medical Device
Crowdfunding
Transportation
Social
Mobile Apps
Automotive
InsurTech
Enterprise
LGBT
Non Profit
Life Science
Theatre
Film
SaaS
Renewable Energy
Sporting Goods
Software
Restaurants
Social Impact
Celebrity
Agriculture (agtech)
Cryptocurrency
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Morocco
Malta
Mali
Malaysia
Turkey
Serbia
Italy
Rwanda
El Salvador
Peru
Venezuela
Ukraine
Lithuania
Myanmar
Portugal
Lebanon
Kuwait
Cayman Islands
Sierra Leone
Zimbabwe
Sweden
Cambodia
Israel
Panama
Taiwan
Mexico
Kazakhstan
Senegal
Liberia
Jersey
Philippines
Uruguay
Uganda
Norway
Tunisia
Mauritius
San Marino
Slovenia
Kenya
Zambia
Liechtenstein
Nicaragua
Uzbekistan
Russian Federation
Dominican Republic
Nigeria
Seychelles
Thailand
Azerbaijan
Namibia
Iceland
Puerto Rico
Iraq
Bahamas
Tajikistan
Togo
Poland
Tanzania
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Grenada
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
VC (Venture Capital) Funds in China by industry
Restaurants
Crowdfunding
Venture Capital
Film
Retail
Publishing
Financial Services
Real Estate
Cryptocurrency
Finance
Payments
Food and Beverage
Wine And Spirits
Organic Food
Video Games
Medical Device
Medical
Internet
Wellness
Social Media
Art
Manufacturing
Digital Media
Blockchain
Music
Mobile
Android
Legal
Non Profit
Software
Local
Enterprise Software
Social Network
Sports
eSports
Fitness
InsurTech
Travel
Automotive
Hospitality
Recruiting
Mobile Advertising
Platforms
FinTech
Biotechnology
Health Care
Enterprise
Climate
Biotech
EdTech
Energy
Sustainability
Proptech
SaaS
Marketplace
Community
Gaming
Hardware
Beauty
Social
Fashion
Infrastructure
B2B
Web3
Sporting Goods
Life Science
Photography
Big Data
Education
Oil and Gas
Clean Energy
Renewable Energy
Construction
Impact
Consumer
Artificial intelligence
Media (entertainment)
Transportation
Agriculture (agtech)
CleanTech
Mobile Apps